XTL BIOPHARMACEUTICALS LTD (XTLB) is a publicly traded company in the Unknown sector. Across all available filings, 6 corporate insiders have executed 190 transactions totaling $100.1M, demonstrating a bullish sentiment with $88.6M in net insider flow. The most recent transaction on Nov 19, 2008 involved a sale of 9,600,000 shares valued at $1.4M.
No significant insider buying has been recorded for XTLB in the recent period.
No significant insider selling has been recorded for XTLB in the recent period.
Based on recent SEC filings, insider sentiment for XTLB is bullish with an Insider Alignment Score of 94/100 and a net flow of $88.6M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at XTL BIOPHARMACEUTICALS LTD (XTLB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 6 insiders are actively trading XTLB stock, having executed 190 transactions in the past 90 days. The most active insider is Life Sciences Master Fund Ltd Perceptive (Executive), who has made 56 transactions totaling $27.8M.
Get notified when executives and directors at XTLB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 19, 2008 | Edelman Joseph | Executive | Sale | 9,600,000 | $0.15 | $1.4M | Large |
| Nov 18, 2008 | Edelman Joseph | Executive | Sale | 29,740 | $0.16 | $4.8K | |
| Nov 18, 2008 | Edelman Joseph | Executive | Sale | 299,570 | $0.15 | $44.9K | |
| Nov 18, 2008 | Edelman Joseph | Executive | Sale | 24,681,360 | $0.14 | $3.5M | Large |
| Nov 18, 2008 | Edelman Joseph | Executive | Sale | 2,696,450 | $0.15 | $404.5K | |
| Nov 18, 2008 | Edelman Joseph | Executive | Sale | 400,000 | $0.16 | $64.0K | |
| Nov 18, 2008 | Edelman Joseph | Executive | Sale | 1,943,250 | $0.14 | $272.1K | |
| Nov 18, 2008 | Edelman Joseph | Executive | Sale | 400,000 | $0.15 | $60.0K | |
| Jun 10, 2008 | Cho Michael | Executive | Purchase | 48,960 | $3.23 | $158.1K | |
| Jun 10, 2008 | Cho Michael | Executive | Purchase | 2,040 | $3.23 | $6.6K | |
| Jun 9, 2008 | Llc Perceptive Advisors | Executive | Purchase | 32,260 | $3.36 | $108.4K | |
| Jun 9, 2008 | Llc Perceptive Advisors | Executive | Purchase | 1,340 | $3.36 | $4.5K | |
| Jun 6, 2008 | Llc Perceptive Advisors | Executive | Purchase | 4,000 | $3.43 | $13.7K | |
| Jun 6, 2008 | Llc Perceptive Advisors | Executive | Purchase | 96,000 | $3.43 | $329.3K | |
| Jun 5, 2008 | Llc Perceptive Advisors | Executive | Purchase | 8,000 | $3.15 | $25.2K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 182 | $94.4M | 94.3% |
Sale(S) | 8 | $5.7M | 5.7% |
Insiders at XTL BIOPHARMACEUTICALS LTD are accumulating shares at an accelerated pace. With 6 insiders making 190 transactions totaling $94.4M in purchases versus $5.7M in sales, the net buying activity of $88.6M signals strong executive confidence. Life Sciences Master Fund Ltd Perceptive (Executive) leads the buying activity with $27.8M in transactions across all time.